This paper is in the following e-collection/theme issue:

Viewpoints and Perspectives (483) E-Health Policy and Health Systems Innovation (207) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (143) Artificial Intelligence (1186) Decision Support for Health Professionals (1127) Safety and Error Prevention in Health (186) Pharmacovigilance (125) Natural Language Processing (636)

Published on in Vol 26 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50274, first published .
Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug Administration

Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug Administration

Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug Administration

Authors of this article:

Robert Ball1 Author Orcid Image ;   Andrew H Talal2 Author Orcid Image ;   Oanh Dang1 Author Orcid Image ;   Monica Muñoz1 Author Orcid Image ;   Marianthi Markatou3 Author Orcid Image
Article Authors Cited by Tweetations (5) Metrics

Robert Ball   1 , MPH, ScM, MD ;   Andrew H Talal   2 , MPH, MD ;   Oanh Dang   1 , PharmD ;   Monica Muñoz   1 , PharmD, PhD ;   Marianthi Markatou   3 , PhD

1 Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States

2 Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, United States

3 School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, United States

Corresponding Author:

  • Robert Ball, MPH, ScM, MD
  • Office of Surveillance and Epidemiology
  • Center for Drug Evaluation and Research
  • US Food and Drug Administration
  • 10903 New Hampshire Avenue
  • Silver Spring, MD, 20993
  • United States
  • Phone: 1 301 796 2380
  • Fax: 1 301 796 9832
  • Email: robert.ball@fda.hhs.gov